"Incretins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Peptides which stimulate INSULIN release from the PANCREATIC BETA CELLS following oral nutrient ingestion, or postprandially.
| Descriptor ID |
D054795
|
| MeSH Number(s) |
D27.505.696.399.472.580
|
| Concept/Terms |
Incretins- Incretins
- Glucose-Dependent Insulin-Releasing Hormone
- Glucose Dependent Insulin Releasing Hormone
- Hormone, Glucose-Dependent Insulin-Releasing
- Insulin-Releasing Hormone, Glucose-Dependent
- Incretin
Incretin Effect- Incretin Effect
- Effect, Incretin
- Incretin Effects
- Effects, Incretin
|
Below are MeSH descriptors whose meaning is more general than "Incretins".
Below are MeSH descriptors whose meaning is more specific than "Incretins".
This graph shows the total number of publications written about "Incretins" by people in this website by year, and whether "Incretins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Incretins" by people in Profiles.
-
Danowitz M, De Leon DD. The Role of GLP-1 Signaling in Hypoglycemia due to Hyperinsulinism. Front Endocrinol (Lausanne). 2022; 13:863184.
-
Hansen M, Scheltema MJ, Sonne DP, Hansen JS, Sperling M, Rehfeld JF, Holst JJ, Vilsb?ll T, Knop FK. Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion. Diabetes Obes Metab. 2016 06; 18(6):571-80.
-
Williamson C, Glauser TA, Burton BS, Schneider D, Dubois AM, Patel D. Health care provider management of patients with type 2 diabetes mellitus: analysis of trends in attitudes and practices. Postgrad Med. 2014 May; 126(3):145-60.
-
Khan MA, Deaton C, Rutter MK, Neyses L, Mamas MA. Incretins as a novel therapeutic strategy in patients with diabetes and heart failure. Heart Fail Rev. 2013 Mar; 18(2):141-8.
-
Mamas MA, Deaton C, Rutter MK, Yuille M, Williams SG, Ray SG, New J, Gibson JM, Neyses L. Impaired glucose tolerance and insulin resistance in heart failure: underrecognized and undertreated? J Card Fail. 2010 Sep; 16(9):761-8.
-
Poornima I, Brown SB, Bhashyam S, Parikh P, Bolukoglu H, Shannon RP. Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart failure-prone rat. Circ Heart Fail. 2008 Sep; 1(3):153-60.